Dr. Reddy's Laboratories Revenue 2015-2024 - Stock Analysis

Dr. Reddy's Laboratories had revenue of 76.73B INR in the quarter ending June 30, 2024, with 13.87% growth. This brings the company's revenue in the last twelve months to 288.51B, up …

CouponFollow Extension

87%
OFF

Dr. Reddy's Laboratories Revenue 2015-2024 - Stock Analysis

1 week from now

Dr. Reddy's Laboratories had revenue of 76.73B INR in the quarter ending June 30, 2024, with 13.87% growth. This brings the company's revenue in the last twelve months to 288.51B, up …

stockanalysis.com

51%
OFF

Dr. Reddy's Laboratories Revenue - Stock Analysis

1 week from now

3 days ago · Dr. Reddy's Laboratories had revenue of 80.16B INR in the quarter ending September 30, 2024, with 16.51% growth. This brings the company's revenue in the last …

stockanalysis.com

97%
OFF

Dr Reddy's Laboratories Revenue 2010-2024 | RDY - Macrotrends

1 week from now

Dr Reddy's Laboratories annual revenue for 2024 was $3.35B, a 11.97% increase from 2023. Dr Reddy's Laboratories annual revenue for 2023 was $2.992B, a 5.87% increase from 2022. Dr …

macrotrends.net

11%
OFF

Dr. Reddys Q4 & Full Year FY24 Financial Results - Dr. Reddy's …

1 week from now

Other Highlights: est, Tax, Depreciation and Amortization (EBITDA) Q4FY24 at ₹ 18.7 b. llion, YoY growth of 15. and QoQ decline of 11%. EBITDA margin is 26.4. .FY24 at ₹ 83.0 bill. Y …

drreddys.com

88%
OFF

Dr Reddys Laboratories Key Financial Ratios, Dr Reddys …

1 week from now

Dr Reddys Labs Consolidated June 2024 Net Sales at Rs 7,696.10 crore, up 13.88% Y-o-Y. Dr Reddys Labs Standalone June 2024 Net Sales at Rs 5,841.20 crore, up 7.43% Y-o-Y. Dr …

moneycontrol.com

87%
OFF

Dr. Reddy's Laboratories Revenue - Stock Analysis

1 week from now

Nov 1, 2024 · Dr. Reddy's Laboratories had revenue of 76.73B INR in the quarter ending June 30, 2024, with 13.87% growth. This brings the company's revenue in the last twelve months to …

stockanalysis.com

74%
OFF

Dr. Reddy's Laboratories Income Statement - Stock Analysis

1 week from now

Mar 31, 2020 · 34.74%. -. Upgrade. Source: S&P Capital IQ. Standard template. Financial Sources. Detailed annual and quarterly income statement for Dr. Reddy's Laboratories (NSE: …

stockanalysis.com

$3
OFF

Industry Update: Dr. Reddy’s Growth Trajectory: Breaking Down …

1 week from now

Jun 12, 2024 · Dr. Reddy’s Laboratories Ltd, a global pharmaceutical leader, has reported its highest ever revenues and profits for the fiscal year 2024. With revenues surpassing $3.3 …

biopharmadive.com

43%
OFF

Dr. Reddy's Laboratories Ratios And Metrics - Stock Analysis

1 week from now

Mar 31, 2020 · 0.43%. 0.89%. Upgrade. Source: S&P Capital IQ. Standard template. Financial Sources. Financial ratios and metrics for Dr. Reddy's Laboratories (NSE: DRREDDY). …

stockanalysis.com

33%
OFF

Dr. Reddy's Laboratories Market Cap - Stock Analysis

1 week from now

4 days ago · Market Cap Chart. Since April 11, 2001, Dr. Reddy's Laboratories's market cap has increased from $839.80M to $12.30B, an increase of 1,364.33%. That is a compound annual …

stockanalysis.com

FAQs about Dr. Reddy's Laboratories Revenue 2015-2024 - Stock Analysis Coupon?

How did Dr Reddy's Laboratories perform in 2024?

Dr. Reddy's Laboratories had revenue of 76.73B INR in the quarter ending June 30, 2024, with 13.87% growth. This brings the company's revenue in the last twelve months to 288.51B, up 10.49% year-over-year. In the fiscal year ending March 31, 2024, Dr. Reddy's Laboratories had annual revenue of 279.16B with 13.54% growth. ...

What is Dr Reddy's lab stock price today?

So, let’s look into Dr. Reddy''s Lab and its performance over the period of time. Dr. Reddy''s Lab stock price today is Rs6999.3. Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Dr. Reddy''s Lab cash from the operating activity was Rs 3449.7 Cr. ...

What happened to Dr Reddy's Laboratories in fy24?

PESG Research releases an industry update following Dr. Reddy's FY24 results. Dr. Reddy’s Laboratories Ltd, a global pharmaceutical leader, has reported its highest ever revenues and profits for the fiscal year 2024. ...

Does Dr Reddy's Laboratories pay a dividend?

Gross margin is 59.06%, with operating and profit margins of 22.74% and 19.26%. This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.61%. The last stock split was on October 28, 2024. It was a forward split with a ratio of 5. Dr. Reddy's Laboratories has an Altman Z-Score of 7.44. ...

What is the operating profit margin of Dr Reddy's lab?

Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dr. Reddy''s Lab has OPM of 30.4170644330162 % which is a good sign for profitability. ROE: Dr. Reddy''s Lab have a average ROE of 19.5418 %. ...

Is Dr Reddy's Laboratories Ltd a good investment?

The promoter holdings of Dr. Reddy's Laboratories Ltd. are relatively stable, which is a positive sign for long-term investors. Dr. Reddy's Laboratories Ltd. has a large number of shareholders, including institutional investors and individual investors. ...